KaliVir Immunotherapeutics
Lisa Butterfield is on the Board of Advisors at KaliVir Immunotherapeutics. Lisa is also the Vice President at Parker Institute for Cancer Immunotherapy.
This person is not in the org chart
This person is not in any offices
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells